The Penn Frontotemporal Degeneration Center will hold its annual FTD Caregiver Conference on Friday, June 14, 2019. The event will be from 8:00 a.m. until 4:30 p.m. in the Smilow Auditorium at the University of Pennsylvania main campus in Philadelphia.
Due to generous donations, this event is offered at no cost for family caregivers, health professionals, scientists, students and anyone with an interest in frontotemporal degeneration. A complimentary lunch will be provided to those who register in advance.
The conference is an opportunity for The Penn FTD Center to showcase its latest work in research and treatment for Frontotemporal Dementia (FTD) and related diseases, including ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig’s Disease) and Corticobasal Degeneration (CBD).
This event will allow caregivers the opportunity to:
- Meet with leading experts in neuropsychology, clinical care, genetics and cognitive neuroscience
- Gain deeper understanding of the latest research-based insights
- Connect and network with other caregivers and advocates
- Discover innovative treatments that Penn offers patients
- Take home practical strategies for caregiving
- Learn how improved diagnostic technology can provide more accurate treatments
- Find out how to prepare for legal considerations related to FTD
Additional breakout sessions at this year’s conference include small-group discussions about:
- specific clinical syndromes to get a better understanding certain situations
- a variety of caregiving situations including communication, behavioral questions, making decisions, and navigating family challenges
For additional information or if you need assistance, please contact Katie via email at firstname.lastname@example.org or by phone at 215-349-5873.
Penn FTD Center Caregiver Conference
Friday, June 14, 2019
8:00 a.m. to 4:30 p.m.
University of Pennsylvania
3400 Civic Center Blvd.
Philadelphia, PA 19104
The Penn Frontotemporal Dementia (FTD) Center is a national leader in research and treatment for FTD and related conditions such as ALS.